Other highlights from the March 21 JNCI

ncern by adopting consistent strategies for interval evaluations in the design phase," the authors write.

Contact: Katherine Panageas, Memorial Sloan-Kettering Cancer Center, panageak@mskcc.org

Mutation to Mismatch Repair Gene Associated with Colorectal Cancer

Patients with a variant of a DNA repair gene, known as MLH1, may have an increased risk of a subtype of colorectal cancer.

Mismatch repair genes fix problems that arise during DNA replication when bases are incorrectly paired. Mutations in these repair genes are associated with increased risks of cancer.

Stavroula Raptis and Miralem Mrkonjic, graduate students at the University of Toronto, and colleagues analyzed two DNA mismatch repair genes, MLH1 and MSH2, in 1,359 colorectal cancer patients and 1,373 controls from Ontario and Newfoundland.

One particular variant in the MLH1 gene, -93G>A, was strongly associated with colorectal cancer. Patients with two copies of this version of the gene had a greater risk of colorectal cancer than patients with only one.

"Decreased levels of MLH1 expression associated with [MLH1 -93G>A] may lead to impaired cell cycle control, allowing cells to proceed with cell division before proper DNA repair can be accomplished. This impaired control would overwhelm the mismatch repair mechanism, leading to the accumulation of mutations," the authors write.

Contact: Nikki Luscombe, Mount Sinai Hospital, (416) 586-4800 ext. 2046, luscombe@mshri.ca


Contact: Liz Savage
Journal of the National Cancer Institute

Page: 1 2 3 4

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights from the July 10 JNCI
4. Other highlights in JNCI, June 26
5. Other highlights in JNCI, June 12
6. Other highlights from the June 6 JNCI
7. Other highlights in the May 16 JNCI
8. Other highlights from the April 18 Journal of the National Cancer Institute
9. Other highlights in the March 7 JNCI
10. Other highlights in the Feb. 21 JNCI
11. Other highlights in the Jan. 17 JNCI

Post Your Comments:

(Date:5/21/2020)... ... May 20, 2020 , ... ... solutions for drugs, biologics, cell and gene therapies, and consumer health products, today ... Therapy, will be presenting at the ISCT 2020 Paris Virtual conference, which takes ...
(Date:5/14/2020)... Kan. (PRWEB) , ... May 13, 2020 , ... ... American launch of Bonlacta™, its latest enzyme for the lactose-free dairy market. This ... a wide range of lactose-free dairy products at competitive costs across North America. ...
(Date:5/1/2020)... Fla. (PRWEB) , ... April 30, 2020 , ... ... telemedicine company backed by Siemens Healthineers and several healthcare VC firms announces an ... the goal of CareDoctors.com is to enhance patient care experience by offering live ...
Breaking Biology News(10 mins):
(Date:4/18/2020)... ... April 17, 2020 , ... NeuroFlow has been ... program to support the expansion of its digital health platform enabling behavioral health ... rigorous merit-based review process, adds to NeuroFlow’s recent government awards . , ...
(Date:4/7/2020)... ... April 06, 2020 , ... Red Nucleus, a leading ... has announced the release of at-home virtual learning resources for all client partners. ... and safety of our employees as we continue to implement measures to safeguard ...
(Date:4/1/2020)... ... March 30, 2020 , ... A joint ... Diagnostics (RID), formed earlier this year to bring telehealth to various government agencies, ... for COVID-19. Company officials are currently?awaiting an Emergency Use Authorization (EUA) waiver from ...
(Date:4/1/2020)... JOLLA, Calif. (PRWEB) , ... March 31, 2020 , ... ... Jolla Institute for Immunology (LJI), announced today that they will use Carterra’s proprietary LSA™ ... move therapeutic candidates to the clinic as early as this summer. , La ...
Breaking Biology Technology:
Cached News: